The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price gain of 24.73% this year. Over the last six months, there has been a stronger performance of -2.19%. The price of ADVM leaped by -33.64% during the last 30 days period. For the last 5-days stocks have slided -15.78%.
Adverum Biotechnologies Inc’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $29.70 on 02/08/24, and the lowest price during that time was $7.10, recorded on 04/28/23.
52-week price history of ADVM Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Adverum Biotechnologies Inc’s current trading price is -68.38% away from its 52-week high, while its distance from the 52-week low is 32.25%. The stock’s price range over this timeframe has been between $7.10 and $29.70. The shares of the Healthcare sector company recorded a trading volume of approximately 0.84 million for the day, which was comparatively higher than the average daily volume of 0.29 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Adverum Biotechnologies Inc (ADVM) has experienced a quarterly rise of 4.92% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 194.84M and boasts a workforce of 121 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 13.18, with a change in price of +1.30. Similarly, Adverum Biotechnologies Inc recorded 206,631 in trading volume during the last 100 days, posting a change of +16.11%.
ADVM’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for ADVM stands at 0.90. Similarly, the long-term debt-to-equity ratio is also 0.77.
ADVM Stock Stochastic Average
The raw stochastic average for Adverum Biotechnologies Inc over the last 50 days is presently at 0.33%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 0.91%. Further, the company’s Stochastic %K and %D values for the last 20 days were 3.47% and 4.95%, respectively.
